Style | Citing Format |
---|---|
MLA | Sajadimajd S, et al.. "Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals." International Immunopharmacology, vol. 114, no. , 2023, pp. -. |
APA | Sajadimajd S, Deravi N, Forouhar K, Rahimi R, Kheirandish A, Bahramsoltani R (2023). Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals. International Immunopharmacology, 114(), -. |
Chicago | Sajadimajd S, Deravi N, Forouhar K, Rahimi R, Kheirandish A, Bahramsoltani R. "Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals." International Immunopharmacology 114, no. (2023): -. |
Harvard | Sajadimajd S et al. (2023) 'Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals', International Immunopharmacology, 114(), pp. -. |
Vancouver | Sajadimajd S, Deravi N, Forouhar K, Rahimi R, Kheirandish A, Bahramsoltani R. Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals. International Immunopharmacology. 2023;114():-. |
BibTex | @article{ author = {Sajadimajd S and Deravi N and Forouhar K and Rahimi R and Kheirandish A and Bahramsoltani R}, title = {Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals}, journal = {International Immunopharmacology}, volume = {114}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Sajadimajd S AU - Deravi N AU - Forouhar K AU - Rahimi R AU - Kheirandish A AU - Bahramsoltani R TI - Endoplasmic Reticulum As a Therapeutic Target in Type 2 Diabetes: Role of Phytochemicals JO - International Immunopharmacology VL - 114 IS - SP - EP - PY - 2023 ER - |